Keyphrases
Post-transplant Lymphoproliferative Disorder
100%
Solid Organ Transplantation
100%
Epstein-Barr Virus
75%
Immunosuppression
25%
Therapeutic Approaches
25%
Rituximab
25%
First Year
25%
Transplantation
25%
Acute Rejection
25%
Immune Status
25%
Combination Chemotherapy
25%
Serious Complications
25%
Immunology and Microbiology
Lymphoproliferative Disorders
100%
Solid Organ Transplantation
100%
Epstein Barr Virus
75%
Immunity
25%
Immunosuppression
25%
Rituximab
25%
Acute Graft Rejection
25%
Pharmacology, Toxicology and Pharmaceutical Science
Posttransplant Lymphoproliferative Disease
100%
Epstein-Barr Virus
75%
Chemotherapy
25%
Rituximab
25%
Acute Graft Rejection
25%